Table 5.
Evaluation of predictive models for MACE.
| C-statistic | NRI | P | IDI | P | |
|---|---|---|---|---|---|
| 30 days | |||||
| FAR | 0.628 (0.560~0.696) | ||||
| ∗Established risk factors | 0.706 (0.633~0.780) | Ref. | Ref. | ||
| Established risk factors + FAR | 0.720 (0.647~0.793) | 0.219 (-0.080~0.315) | 0.084 | 0.005 (-0.002~0.022) | 0.172 |
| 6 months | |||||
| FAR | 0.609 (0.556~0.661) | ||||
| ∗∗Established risk factors | 0.650 (0.590~0.710) | Ref. | |||
| Established risk factors + FAR | 0.668 (0.612~0.725) | 0.155 (-0.037~0.263) | 0.070 | 0.003 (-0.001~0.014) | 0.222 |
| 1 year | |||||
| FAR | 0.593 (0.549~0.637) | ||||
| ∗∗∗Established risk factors | 0.611 (0.561~0.661) | Ref. | Ref. | ||
| Established risk factors + FAR | 0.632 (0.585~0.680) | 0.136 (0.005~0.211) | 0.044 | 0.006 (0.000~0.019) | 0.042 |
FAR: fibrinogen-to-albumin ratio; NRI: net reclassification improvement; IDI: integrated discrimination improvement; MACE: major adverse cardiovascular event; ∗Established risk factors included female, BMI and NSTEMI; ∗∗Established risk factors included BMI and NSTEMI; ∗∗∗Established risk factors included BMI and NSTEMI.